• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型冠状病毒(严重急性呼吸综合征冠状病毒2)与冠状病毒病2019。

A novel coronavirus (SARS-CoV-2) and COVID-19.

作者信息

Trojánek Milan, Grebenyuk Vyacheslav, Herrmannová Kristýna, Nečas Tomáš, Gregorová Jana, Kucbel Martin, Šín Robin, Roháčová Hana, Stejskal František

出版信息

Cas Lek Cesk. 2020 Spring;159(2):55-66.

PMID:32434337
Abstract

By the end of 2019 the first cases of severe pneumonia of unknown origin were reported in Wuhan, China. The causative agent was identified as a novel b-coronavirus SARS-CoV-2 and the disease was named COVID-19. Since the beginning of 2020, the infection has spread worldwide, which led the WHO to declare COVID-19 a public health emergency of international concern and to characterize the current situation as a pandemic. The transmission occurs mainly via respiratory droplets and the incubation period ranges from 2 to 14 days. Most cases are mild, but some patients develop severe pneumonia with acute respiratory distress, septic shock and multi-organ failure. The most common symptoms include fever, dry cough, myalgia and shortness of breath. Characteristic laboratory findings are normal white blood cell count or mild leukopenia, marked lymphopenia, in severe cases elevated CRP, procalcitonin, LDH, and D-dimer are commonly found. Typical imaging findings include multifocal peripherally distributed ground-glass opacities or consolidations, interlobular septal thickening, crazy paving appearance and cystic changes. The overall case fatality rate is estimated to range from 1 to 3 %, however, it is dependent on age and underlying medical comorbidities. Current potential treatment options include hydroxychloroquine, remdesivir, lopinavir/ritonavir and convalescent plasma.

摘要

2019年底,中国武汉报告了首例不明原因的重症肺炎病例。病原体被确定为一种新型β冠状病毒SARS-CoV-2,该疾病被命名为COVID-19。自2020年初以来,这种感染已在全球范围内传播,这使得世界卫生组织宣布COVID-19为国际关注的突发公共卫生事件,并将当前形势定性为大流行。传播主要通过呼吸道飞沫进行,潜伏期为2至14天。大多数病例症状较轻,但一些患者会发展为重症肺炎,伴有急性呼吸窘迫、感染性休克和多器官功能衰竭。最常见的症状包括发热、干咳、肌痛和呼吸急促。典型的实验室检查结果是白细胞计数正常或轻度白细胞减少、明显淋巴细胞减少,在重症病例中,常见CRP、降钙素原、乳酸脱氢酶和D-二聚体升高。典型的影像学表现包括多灶性外周分布的磨玻璃影或实变、小叶间隔增厚、铺路石样外观和囊性改变。总体病死率估计在1%至3%之间,然而,这取决于年龄和潜在的合并症。目前可能的治疗选择包括羟氯喹、瑞德西韦、洛匹那韦/利托那韦和康复期血浆。

相似文献

1
A novel coronavirus (SARS-CoV-2) and COVID-19.一种新型冠状病毒(严重急性呼吸综合征冠状病毒2)与冠状病毒病2019。
Cas Lek Cesk. 2020 Spring;159(2):55-66.
2
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
3
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.中国武汉以外地区多次 PCR 检测结果为阴性的 COVID-19 患者:一例病例报告。
BMC Infect Dis. 2020 Jul 16;20(1):517. doi: 10.1186/s12879-020-05245-7.
4
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department].[儿科急诊科中严重急性呼吸综合征冠状病毒2型聚合酶链反应阳性病例的评估]
Mikrobiyol Bul. 2020 Oct;54(4):629-637. doi: 10.5578/mb.70086.
5
Clinical characteristics of 16 patients with fecal severe acute respiratory syndrome coronavirus 2 nucleic acid-positive.16例粪便严重急性呼吸综合征冠状病毒2核酸阳性患者的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):560-564. doi: 10.11817/j.issn.1672-7347.2020.200230.
6
Clinical characteristics of 71 patients with coronavirus disease 2019.71例2019冠状病毒病患者的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jul 28;45(7):790-796. doi: 10.11817/j.issn.1672-7347.2020.200187.
7
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
8
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
9
Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.牛和猪呼吸道冠状病毒与人类 SARS-CoV-2 在动物宿主物种中的比较发病机制。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01355-20.
10
An update on novel COVID-19 pandemic: a battle between humans and virus.关于新型 COVID-19 大流行的最新情况:人类与病毒之间的战斗。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5819-5829. doi: 10.26355/eurrev_202005_21377.

引用本文的文献

1
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants.针对 SARS-CoV-2 变体的抗病毒药物研发,靶向受体结合域和硫酸乙酰肝素结合。
Sci Rep. 2024 Feb 2;14(1):2753. doi: 10.1038/s41598-024-53111-2.
2
Early changes in laboratory tests predict liver function damage in patients with moderate coronavirus disease 2019: a retrospective multicenter study.早期实验室检查变化可预测中症 COVID-19 患者的肝功能损伤:一项回顾性多中心研究。
BMC Gastroenterol. 2022 Mar 9;22(1):113. doi: 10.1186/s12876-022-02188-y.